Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Inflammatory Carcinoma”

134 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 134 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05383196
What this trial is testing

Onvansertib + Paclitaxel In TNBC

Who this might be right for
Breast CancerInvasive Breast CancerUnresectable Breast Carcinoma+7 more
Antonio Giordano, MD 50
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Testing effectiveness (Phase 2)Study completedNCT01796197
What this trial is testing

Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT02876107
What this trial is testing

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

Who this might be right for
Breast CarcinomaBreast LumpEdema+8 more
M.D. Anderson Cancer Center 42
Very early researchStudy completedNCT01894451
What this trial is testing

Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy

Who this might be right for
Inflammatory Breast Carcinoma
Dana-Farber Cancer Institute 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT02971748
What this trial is testing

Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy

Who this might be right for
Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Breast Inflammatory Carcinoma+2 more
M.D. Anderson Cancer Center 36
Not applicableStudy completedNCT01231386
What this trial is testing

MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 199
Testing effectiveness (Phase 2)Study completedNCT00558103
What this trial is testing

Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 163
Early research (Phase 1)UnknownNCT00002616
What this trial is testing

Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
University of Illinois at Chicago 36
Large-scale testing (Phase 3)UnknownNCT02879513
What this trial is testing

Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

Who this might be right for
Invasive Ductal Breast CancerTubular Breast CancerMucinous Breast Cancer+1 more
RenJi Hospital 290
Testing effectiveness (Phase 2)Active Not RecruitingNCT02411656
What this trial is testing

Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

Who this might be right for
EdemaErythemaEstrogen Receptor Negative+6 more
M.D. Anderson Cancer Center 71
Testing effectiveness (Phase 2)UnknownNCT00398489
What this trial is testing

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

Who this might be right for
Breast Cancer
Technical University of Munich 94
Testing effectiveness (Phase 2)Ended earlyNCT02658812
What this trial is testing

Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by Surgery

Who this might be right for
Malignant Chest Wall NeoplasmRecurrent Breast CarcinomaRecurrent Inflammatory Breast Carcinoma+2 more
M.D. Anderson Cancer Center 11
Early research (Phase 1)Study completedNCT00005822
What this trial is testing

SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT03742986
What this trial is testing

Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC)

Who this might be right for
Breast Cancer
NYU Langone Health 8
Not applicableNot Yet RecruitingNCT06131632
What this trial is testing

Conserving Surgery in Inflammatory Breast Cancer After Neoadjuvant Chemotherapy

Who this might be right for
Inflammatory Breast Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 300
Not applicableLooking for participantsNCT05178498
What this trial is testing

Impact of Dietary Inflammatory Potential on Breast Cancer Risk

Who this might be right for
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Carcinoma+2 more
Ohio State University Comprehensive Cancer Center 960
Testing effectiveness (Phase 2)Study completedNCT00182793
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 32
Testing effectiveness (Phase 2)UnknownNCT00002627
What this trial is testing

Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer

Who this might be right for
Breast Cancer
St. Louis University 30
Testing effectiveness (Phase 2)Ended earlyNCT05243641
What this trial is testing

Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis Test

Who this might be right for
Metastatic Breast CancerBreast Cancer
M.D. Anderson Cancer Center 10
Next Page